Drug intelligence / Profile preview

[18F]AldoView

Development stage
Unknown
Lead developer
University College London
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[18F]AldoView is a fluorine-18 labeled, highly selective positron emission tomography (PET) tracer designed to target and image aldosterone synthase (CYP11B2) expression in the adrenal glands. It acts as a potent and selective inhibitor of human CYP11B2, with minimal off-target binding to CYP11B1, enabling noninvasive detection and subtyping of primary aldosteronism (PA), particularly for identifying aldosterone-producing adenomas (APAs) and nodules. The tracer demonstrates high metabolic stability, favorable pharmacokinetics, rapid distribution and clearance in preclinical models, and strong correlation between PET signal intensity and CYP11B2 expression in resected tissue. First-in-human studies confirm its safety, feasibility for clinical imaging of PA patients, and potential utility for guiding diagnosis and management of hyperaldosteronism[1][2][3][4][5][6].

Brand names
[18F]AldoView
Other names
18F-AldoViewFluorine-18 AldoViewFluorine18 AldoViewFluorine 18 AldoView
02

Targets

CYP11B2 (Cytochrome P450 11B2)

Beyond the preview

Go deeper on [18F]AldoView.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]AldoView.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call